Edward Carr

Insider Reports History

Entity
Individual
Location
1330 Avenue Of The Americas, 33 Rd Floor, New York, NY
Signature
/s/ Adam Veness, as attorney-in-fact for Edward Carr
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Edward Carr:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ABEONA THERAPEUTICS INC. Chief Financial Officer Common stock 400K $2.04M $5.11 Oct 8, 2021 Direct
ABEONA THERAPEUTICS INC. Chief Financial Officer Stock Option (right to buy) 476K Aug 10, 2021 Direct
Dianthus Therapeutics, Inc. /DE/ CHIEF ACCOUNTING OFFICER Stock Option (Right to Buy) 60K May 23, 2024 Direct

Insider Reports Filed by Edward Carr

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DNTH Dianthus Therapeutics, Inc. /DE/ May 23, 2024 1 $0 4 May 28, 2024 CHIEF ACCOUNTING OFFICER
DNTH Dianthus Therapeutics, Inc. /DE/ Jan 24, 2024 1 $0 4 Jan 26, 2024 CHIEF ACCOUNTING OFFICER
DNTH Dianthus Therapeutics, Inc. /DE/ Sep 11, 2023 0 $0 3 Sep 13, 2023 CHIEF ACCOUNTING OFFICER
ABEO ABEONA THERAPEUTICS INC. Oct 8, 2021 1 -$30.6K 4 Oct 8, 2021 Chief Financial Officer
ABEO ABEONA THERAPEUTICS INC. Aug 10, 2021 2 $0 4 Aug 12, 2021 Chief Financial Officer